Secure Message for Polyps of Colon

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Kaiser Permanente San Francisco Medical Center, San Francisco, CA
Polyps of Colon+2 More
Outreach - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to compare the effectiveness of three standard of care outreach approaches (i.e., mailed letter, secure message, and telephone call) on patient adoption of the new 10-year colonoscopy surveillance interval recommendation for a random sample of health plan members who have a now-outdated 5-year surveillance interval due to a finding of 1-2 small adenomas at their prior colonoscopy. The primary study endpoint is the proportion of patients in each outreach arm who adopt the new 10-year colonoscopy surveillance interval.

Eligible Conditions

  • Polyps of Colon

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 2 months following outreach intervention

Month 2
Percentage of patients requesting a physician appointment
Percentage of patients who respond with a 10-year surveillance interval change

Trial Safety

Trial Design

3 Treatment Groups

Secure Message
1 of 3
Telephone Outreach
1 of 3
Mailed Letter
1 of 3
Active Control
Non-Treatment Group

600 Total Participants · 3 Treatment Groups

Primary Treatment: Secure Message · Has Placebo Group · N/A

Secure Message
Behavioral
ActiveComparator Group · 1 Intervention: Outreach · Intervention Types: Behavioral
Mailed Letter
Behavioral
PlaceboComparator Group · 1 Intervention: Outreach · Intervention Types: Behavioral
Telephone Outreach
Behavioral
ActiveComparator Group · 1 Intervention: Outreach · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months following outreach intervention
Closest Location: Kaiser Permanente San Francisco Medical Center · San Francisco, CA
Photo of San Francisco 1Photo of San Francisco 2Photo of San Francisco 3
2020First Recorded Clinical Trial
1 TrialsResearching Polyps of Colon
1 CompletedClinical Trials

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
496 Previous Clinical Trials
22,185,587 Total Patients Enrolled
Jeffrey K Lee, MDStudy ChairKaiser Permanente
1 Previous Clinical Trials
740 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a patient of KP San Rafael, KP San Leandro, KP Walnut Creek, or KP San Francisco.
You are due for your 5-year surveillance colonoscopy in 2022.
The average risk for CRC is low.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.